Previous studies suggest that activating or enhancing RORA expression may strengthen antitumor immune responses and improve the effectiveness of existing immunotherapies, such as immune checkpoint inhibitors [52].Our analysis also revealed a significant inverse correlation between RORA expression and tumor mutational burden (TMB). Here, RORA is linked to neoplasm.